link
Bookmarks
Breast Malignancy
Fathima Fijula P. Manzil, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
1
4
0

KEY FACTS

  • Imaging

    • Pathology

      • Clinical Issues

        • Diagnostic Checklist

          IMAGING

          • General Features

            • Nuclear Medicine Findings

              • Imaging Recommendations

                DIFFERENTIAL DIAGNOSIS

                  PATHOLOGY

                  • General Features

                    • Staging, Grading, & Classification

                      • Gross Pathologic & Surgical Features

                        • Microscopic Features

                          CLINICAL ISSUES

                          • Presentation

                            • Demographics

                              • Natural History & Prognosis

                                • Treatment

                                  DIAGNOSTIC CHECKLIST

                                  • Consider

                                    • Image Interpretation Pearls

                                      Selected References

                                      1. Chang CC et al: Prognostic significance of metabolic parameters and textural features on 18F-FDG PET/CT in invasive ductal carcinoma of breast. Sci Rep. 9(1):10946, 2019
                                      2. Hildebrandt MG et al: FDG-PET/CT for response monitoring in metastatic breast cancer: Today, tomorrow, and beyond. Cancers (Basel). 11(8), 2019
                                      3. Sakaguchi R et al: Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. Ann Nucl Med. 33(8):570-8, 2019
                                      4. Yano F et al: Diagnostic accuracy of positron emission mammography with 18F-fluorodeoxyglucose in breast cancer tumor of less than 20 mm in size. Asia Ocean J Nucl Med Biol. 7(1):13-21, 2019
                                      5. Kalli S et al: American Joint Committee on Cancer's staging system for breast cancer, Eighth Edition: what the radiologist needs to know. Radiographics. 38(7):1921-33, 2018
                                      6. Narayanan D et al: Dedicated breast gamma camera imaging and breast PET: current status and Future directions. PET Clin. 13(3):363-81, 2018
                                      7. Fowler AM: A molecular approach to breast imaging. J Nucl Med. 55(2):177-80, 2014
                                      8. Glass SB et al: Clinical utility of positron emission mammography. Proc (Bayl Univ Med Cent). 26(3):314-9, 2013
                                      9. Hruska CB et al: Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys. 40(5):050901, 2013
                                      10. Kalles V et al: The current status of positron emission mammography in breast cancer diagnosis. Breast Cancer. 20(2):123-30, 2013
                                      11. Ling CM et al: Breast-specific gamma imaging in the detection of atypical ductal hyperplasia and lobular neoplasia. Acad Radiol. 19(6):661-6, 2012
                                      12. Hruska CB et al: Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 191(6):1805-15, 2008
                                      13. Berg WA et al: High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 12(4):309-23, 2006
                                      14. Kumar R et al: Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 98(3):267-74, 2006
                                      15. Kumar R et al: Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status. Mol Imaging Biol. 8(6):355-62, 2006
                                      16. Pelosi E et al: Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging. 31(7):932-9, 2004
                                      17. Zangheri B et al: PET/CT and breast cancer. Eur J Nucl Med Mol Imaging. 31 Suppl 1:S135-42, 2004
                                      18. Vranjesevic D et al: Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 44(8):1238-42, 2003
                                      19. Bos R et al: Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 20(2):379-87, 2002
                                      20. Schirrmeister H et al: Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med. 28(3):351-8, 2001
                                      21. Palmedo H et al: Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med. 25(4):375-85, 1998
                                      22. Waxman AD: The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med. 27(1):40-54, 1997
                                      23. Khalkhali I et al: Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 178(5):491-7, 1994
                                      24. Waxman AD et al: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med. 34(1):18-23, 1993
                                      Related Anatomy
                                      Loading...
                                      Related Differential Diagnoses
                                      Loading...
                                      References
                                      Tables

                                      Tables

                                      KEY FACTS

                                      • Imaging

                                        • Pathology

                                          • Clinical Issues

                                            • Diagnostic Checklist

                                              IMAGING

                                              • General Features

                                                • Nuclear Medicine Findings

                                                  • Imaging Recommendations

                                                    DIFFERENTIAL DIAGNOSIS

                                                      PATHOLOGY

                                                      • General Features

                                                        • Staging, Grading, & Classification

                                                          • Gross Pathologic & Surgical Features

                                                            • Microscopic Features

                                                              CLINICAL ISSUES

                                                              • Presentation

                                                                • Demographics

                                                                  • Natural History & Prognosis

                                                                    • Treatment

                                                                      DIAGNOSTIC CHECKLIST

                                                                      • Consider

                                                                        • Image Interpretation Pearls

                                                                          Selected References

                                                                          1. Chang CC et al: Prognostic significance of metabolic parameters and textural features on 18F-FDG PET/CT in invasive ductal carcinoma of breast. Sci Rep. 9(1):10946, 2019
                                                                          2. Hildebrandt MG et al: FDG-PET/CT for response monitoring in metastatic breast cancer: Today, tomorrow, and beyond. Cancers (Basel). 11(8), 2019
                                                                          3. Sakaguchi R et al: Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. Ann Nucl Med. 33(8):570-8, 2019
                                                                          4. Yano F et al: Diagnostic accuracy of positron emission mammography with 18F-fluorodeoxyglucose in breast cancer tumor of less than 20 mm in size. Asia Ocean J Nucl Med Biol. 7(1):13-21, 2019
                                                                          5. Kalli S et al: American Joint Committee on Cancer's staging system for breast cancer, Eighth Edition: what the radiologist needs to know. Radiographics. 38(7):1921-33, 2018
                                                                          6. Narayanan D et al: Dedicated breast gamma camera imaging and breast PET: current status and Future directions. PET Clin. 13(3):363-81, 2018
                                                                          7. Fowler AM: A molecular approach to breast imaging. J Nucl Med. 55(2):177-80, 2014
                                                                          8. Glass SB et al: Clinical utility of positron emission mammography. Proc (Bayl Univ Med Cent). 26(3):314-9, 2013
                                                                          9. Hruska CB et al: Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys. 40(5):050901, 2013
                                                                          10. Kalles V et al: The current status of positron emission mammography in breast cancer diagnosis. Breast Cancer. 20(2):123-30, 2013
                                                                          11. Ling CM et al: Breast-specific gamma imaging in the detection of atypical ductal hyperplasia and lobular neoplasia. Acad Radiol. 19(6):661-6, 2012
                                                                          12. Hruska CB et al: Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 191(6):1805-15, 2008
                                                                          13. Berg WA et al: High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 12(4):309-23, 2006
                                                                          14. Kumar R et al: Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 98(3):267-74, 2006
                                                                          15. Kumar R et al: Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status. Mol Imaging Biol. 8(6):355-62, 2006
                                                                          16. Pelosi E et al: Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging. 31(7):932-9, 2004
                                                                          17. Zangheri B et al: PET/CT and breast cancer. Eur J Nucl Med Mol Imaging. 31 Suppl 1:S135-42, 2004
                                                                          18. Vranjesevic D et al: Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 44(8):1238-42, 2003
                                                                          19. Bos R et al: Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 20(2):379-87, 2002
                                                                          20. Schirrmeister H et al: Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med. 28(3):351-8, 2001
                                                                          21. Palmedo H et al: Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med. 25(4):375-85, 1998
                                                                          22. Waxman AD: The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med. 27(1):40-54, 1997
                                                                          23. Khalkhali I et al: Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 178(5):491-7, 1994
                                                                          24. Waxman AD et al: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med. 34(1):18-23, 1993